10-Q: Crescent Capital BDC Reports Third Quarter 2024 Results
Quarterly Report
Crescent Capital BDC reports its investment portfolio and financial results for the third quarter of 2024, detailing various debt and equity investments.
Summary
- Crescent Capital BDC's 10-Q filing for the quarter ended September 30, 2024, details its investment portfolio, which includes a variety of debt and equity investments.
- The company's investments are primarily in secured debt, unitranche first lien, and second lien debt, as well as related equity securities of private U.S. middle-market companies.
- The filing also includes information on the company's financial condition, results of operations, and cash flows for the three and nine months ended September 30, 2024 and 2023.
- The company's total assets were $1,645.0 million as of September 30, 2024, compared to $1,627.4 million as of December 31, 2023.
- The company's total net assets were $748.8 million as of September 30, 2024, compared to $742.6 million as of December 31, 2023.
- The company's net investment income was $23.5 million for the three months ended September 30, 2024, and $68.6 million for the nine months ended September 30, 2024.
- The company's net realized and unrealized losses on investments were $8.2 million for the three months ended September 30, 2024, and $5.4 million for the nine months ended September 30, 2024.
- The company's net increase in net assets resulting from operations was $15.3 million for the three months ended September 30, 2024, and $63.7 million for the nine months ended September 30, 2024.
- The company's net asset value per share was $20.20 as of September 30, 2024, compared to $20.04 as of December 31, 2023.
Sentiment
Score: 5
Explanation: The document presents a mixed picture with positive growth in assets and net investment income, but also significant unrealized losses. The overall sentiment is neutral to slightly negative due to the losses.
Positives
- The company's total assets and net assets increased compared to December 31, 2023.
- The company's net investment income increased for the nine months ended September 30, 2024 compared to the same period in 2023.
- The company's net asset value per share increased from $20.04 as of December 31, 2023 to $20.20 as of September 30, 2024.
Negatives
- The company's net realized and unrealized losses on investments were $8.2 million for the three months ended September 30, 2024, and $5.4 million for the nine months ended September 30, 2024.
Risks
- The company is subject to financial market risks, including valuation risk, interest rate risk and currency risk.
- The company's investments are primarily in illiquid debt and equity securities of private companies, which may not have a readily available market price.
- The company's net investment income will be affected by the difference between the rate at which it invests and the rate at which it borrows.
- The company is exposed to movements in foreign exchange rates on investments denominated in foreign currencies.
Future Outlook
The company expects its investment activity to vary substantially from period to period depending on many factors, the general economic environment, the amount of capital it has available, the level of merger and acquisition activity for middle-market companies, including the amount of debt and equity capital available to such companies and the competitive environment for the type of investments it makes.
Industry Context
The company operates in the specialty finance industry, focusing on lending to middle-market companies. The company's performance is influenced by factors such as the general economic environment, the amount of capital available, and the competitive landscape for investments.
Comparison to Industry Standards
- The company's investment portfolio is diversified across various industries, including Health Care Equipment & Services, Software & Services, and Commercial & Professional Services.
- The company's investment strategy focuses on secured debt, unitranche first lien, and second lien debt, as well as related equity securities of private U.S. middle-market companies, which is a common approach in the BDC industry.
- The company's use of leverage is subject to the limitations of the 1940 Act, which is a standard practice for BDCs.
- The company's use of a multi-step valuation process, including independent third-party valuation firms, is consistent with industry best practices for valuing illiquid investments.
Legal Proceedings
- The company is party to certain lawsuits in the normal course of business, including proceedings relating to the enforcement of its rights under loans to or other contracts with its portfolio companies.
Related Party Transactions
- The company has entered into an administration agreement with the Administrator, which is an affiliate of the Adviser.
- The company has entered into an investment advisory agreement with the Adviser.
- A portion of the outstanding shares of the Companys common stock is owned by Crescent, its employees and certain officers and directors of the Company.
- The company has entered into a license agreement with Crescent under which Crescent granted the Company a non-exclusive, royalty-free license to use the name Crescent Capital.
- The Adviser has entered into a resource sharing agreement with Crescent.
- Sun Life is the sole lender of the Companys Series 2023A Unsecured Notes and a $10,000 participating lender in the Companys Series 2021A Unsecured Notes.
Stakeholder Impact
- The company's performance will impact its shareholders through changes in net asset value and dividend distributions.
- The company's investment activities will impact its portfolio companies through the provision of capital and ongoing monitoring.
- The company's financial condition will impact its creditors through the repayment of debt obligations.
Next Steps
- The company will continue to monitor its portfolio companies and assess the risk profile of each investment.
- The company will continue to evaluate opportunities for new investments and capital raising.
- The company will continue to comply with the applicable provisions of the Code, pertaining to regulated investment companies and to make distributions of taxable income sufficient to relieve it from substantially all federal income taxes.
Key Dates
| Date | Description |
|---|---|
| 2015-02-05 | Crescent Capital BDC, Inc. was formed as a Delaware corporation. |
| 2015-06-26 | The Company commenced investment operations. |
| 2020-01-30 | The Company changed its state of incorporation from Delaware to Maryland. |
| 2020-02-03 | The Company was listed and began trading on the NASDAQ stock exchange. |
| 2021-01-05 | Sun Life Financial Inc. acquired a majority interest in Crescent Capital Group LP. |
| 2023-03-09 | The Company completed its acquisition of First Eagle Alternative Capital BDC, Inc. |
| 2024-05-31 | CCAP SPV entered into the Seventh Amendment to Loan and Security Agreement. |
| 2024-09-30 | The end of the reporting period for the 10-Q filing. |
| 2024-11-06 | The Company's Board of Directors declared a regular fourth quarter cash dividend of $0.42 per share and a supplemental cash dividend of $0.07 per share. |
| 2024-11-12 | The date of the filing of the 10-Q report. |
| 2024-11-29 | Record date for the supplemental cash dividend of $0.07 per share. |
| 2024-12-16 | Payment date for the supplemental cash dividend of $0.07 per share. |
| 2024-12-31 | Record date for the regular fourth quarter cash dividend of $0.42 per share. |
| 2025-01-15 | Payment date for the regular fourth quarter cash dividend of $0.42 per share. |
Keywords
investments, debt, equity, financial results, portfolio, middle-market, interest rate, credit, unsecured, secured
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.